Mealey's (July 15, 2020, 10:15 AM EDT) -- PHILADELPHIA — Glenmark Pharmaceuticals Inc. USA on June 30 was charged by the United States with one count of conspiring with other generic drug manufacturers to restrain trade in violation of the Sherman Act, 15 U.S. Code § 1 (United States v. Glenmark Pharmaceuticals Inc., USA, No. 20-cr-200, E.D. Pa.)....